BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33485775)

  • 1. Comparison of combined heart‒liver vs heart-only transplantation in pediatric and young adult Fontan recipients.
    Sganga D; Hollander SA; Vaikunth S; Haeffele C; Bensen R; Navaratnam M; McDonald N; Profita E; Maeda K; Concepcion W; Bernstein D; Chen S
    J Heart Lung Transplant; 2021 Apr; 40(4):298-306. PubMed ID: 33485775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes.
    Cotter TG; Wang J; Peeraphatdit T; Sandıkçı B; Ayoub F; Kim G; Te H; Jeevanandam V; Sabato D; Charlton M
    Hepatology; 2021 Apr; 73(4):1464-1477. PubMed ID: 32559317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Adult Fontan-Associated Liver Disease and Combined Heart-Liver Transplantation.
    Lewis MJ; Reardon LC; Aboulhosn J; Haeffele C; Chen S; Kim Y; Fuller S; Forbess L; Alshawabkeh L; Urey MA; Book WM; Rodriguez F; Menachem JN; Clark DE; Valente AM; Carazo M; Egbe A; Connolly HM; Krieger EV; Angiulo J; Cedars A; Ko J; Jacobsen RM; Earing MG; Cramer JW; Ermis P; Broda C; Nugaeva N; Ross H; Awerbach JD; Krasuski RA; Rosenbaum M
    J Am Coll Cardiol; 2023 Jun; 81(22):2149-2160. PubMed ID: 37257950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fontan Patient Survival After Pediatric Heart Transplantation Has Improved in the Current Era.
    Simpson KE; Pruitt E; Kirklin JK; Naftel DC; Singh RK; Edens RE; Barnes AP; Canter CE
    Ann Thorac Surg; 2017 Apr; 103(4):1315-1320. PubMed ID: 27863728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function.
    Simpson KE; Esmaeeli A; Khanna G; White F; Turnmelle Y; Eghtesady P; Boston U; Canter CE
    J Heart Lung Transplant; 2014 Feb; 33(2):170-7. PubMed ID: 24365764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous outcomes of liver disease after heart transplantation for a failed Fontan procedure.
    Ybarra AM; Khanna G; Turmelle YP; Stoll J; Castleberry CD; Scheel J; Ballweg JA; Ameduri R; Kimberling M; Makil E; Birnbaum BF; Exil V; Canter CE; Simpson KE
    Pediatr Transplant; 2021 Dec; 25(8):e14094. PubMed ID: 34296503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease.
    Lamour JM; Kanter KR; Naftel DC; Chrisant MR; Morrow WR; Clemson BS; Kirklin JK; ;
    J Am Coll Cardiol; 2009 Jul; 54(2):160-5. PubMed ID: 19573734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The majority of pediatric Fontan patients have excellent post-transplant survival.
    Kulshrestha K; Greenberg JW; Kennedy JT; Hogue S; Winlaw DS; Ashfaq A; Zafar F; Morales DLS
    J Thorac Cardiovasc Surg; 2024 Jun; 167(6):2193-2203. PubMed ID: 37774778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart and heart-liver transplantation in adults with failing Fontan physiology.
    Reardon LC; DePasquale EC; Tarabay J; Cruz D; Laks H; Biniwale RM; Busuttil RW; Kaldas FM; Saab S; Venick RS; Lin JP; Nsair A; Deng MC; Ardehali A; Caderias M; Iygengar A; Aboulhosn JA
    Clin Transplant; 2018 Aug; 32(8):e13329. PubMed ID: 29947122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-Kidney and Heart-Liver Transplantation Provide Immunoprotection to the Cardiac Allograft.
    Chou AS; Habertheuer A; Chin AL; Sultan I; Vallabhajosyula P
    Ann Thorac Surg; 2019 Aug; 108(2):458-466. PubMed ID: 30885846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric heart-liver transplant outcomes in the United States: A 25-year National Cohort Study.
    Choudhry S; Dreyer WJ; Hope KD; Wang Y; Spinner JA; Tunuguntla HP; Cabrera AG; Price JF; Denfield SW
    Pediatr Transplant; 2021 Nov; 25(7):e14066. PubMed ID: 34120386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
    Lewis MJ; Reardon LC; Aboulhosn J; Haeffele C; Chen S; Kim Y; Fuller S; Forbess L; Alshawabkeh L; Urey MA; Book WM; Rodriguez F; Menachem JN; Clark DE; Valente AM; Carazo M; Egbe A; Connolly HM; Krieger EV; Angiulo J; Cedars A; Ko J; Jacobsen RM; Earing MG; Cramer JW; Ermis P; Broda C; Nugaeva N; Ross H; Awerbach JD; Krasuski RA; Rosenbaum M
    J Am Coll Cardiol; 2023 Jun; 81(22):2161-2171. PubMed ID: 37257951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality Risk Stratification in Fontan Patients Who Underwent Heart Transplantation.
    Berg CJ; Bauer BS; Hageman A; Aboulhosn JA; Reardon LC
    Am J Cardiol; 2017 May; 119(10):1675-1679. PubMed ID: 28341356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fontan-associated protein-losing enteropathy and post‒heart transplant outcomes: A multicenter study.
    Schumacher KR; Yu S; Butts R; Castleberry C; Chen S; Edens E; Godown J; Johnson J; Kemna M; Lin K; Lowery R; Simpson K; West S; Wilmot I; Gossett JG
    J Heart Lung Transplant; 2019 Jan; 38(1):17-25. PubMed ID: 30391195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart transplantation and in-hospital outcomes in adult congenital heart disease patients with Fontan: A decade nationwide analysis from 2004 to 2014.
    Hernandez GA; Lemor A; Clark D; Blumer V; Burstein D; Byrne R; Fowler R; Frischhertz B; Sandhaus E; Schlendorf K; Zalawadiya S; Lindenfeld J; Menachem JN
    J Card Surg; 2020 Mar; 35(3):603-608. PubMed ID: 31971277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients.
    Amdani S; Simpson KE; Thrush P; Shih R; Simmonds J; Knecht K; Mogul DB; Hurley K; Koehl D; Cantor R; Naftel D; Kirklin JK; Daly KP
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1462-1473.e12. PubMed ID: 33745714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart transplantation in Fontan patients across Australia and New Zealand.
    Shi WY; Yong MS; McGiffin DC; Jain P; Ruygrok PN; Marasco SF; Finucane K; Keogh A; d'Udekem Y; Weintraub RG; Konstantinov IE
    Heart; 2016 Jul; 102(14):1120-6. PubMed ID: 27000055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver abnormalities and post-transplant survival in pediatric Fontan patients.
    Hofferberth SC; Singh TP; Bastardi H; Blume ED; Fynn-Thompson F
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 29105236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure.
    Atz AM; Zak V; Mahony L; Uzark K; D'agincourt N; Goldberg DJ; Williams RV; Breitbart RE; Colan SD; Burns KM; Margossian R; Henderson HT; Korsin R; Marino BS; Daniels K; McCrindle BW;
    J Am Coll Cardiol; 2017 Jun; 69(22):2735-2744. PubMed ID: 28571639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current outcomes of the bi-directional cavopulmonary anastomosis in single ventricle patients: analysis of risk factors for morbidity and mortality, and suitability for Fontan completion.
    François K; Vandekerckhove K; De Groote K; Panzer J; De Wolf D; De Wilde H; Bové T
    Cardiol Young; 2016 Feb; 26(2):288-97. PubMed ID: 25704070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.